These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2867948)

  • 21. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the metabolism of dimethylnitrosamine in vitro by rat-liver preparations. II. Inhibition by substrates and inhibitors of monoamine oxidase.
    Lake BG; Harris RA; Collins MA; Cottrell RC; Phillips JC; Gangolli SD
    Xenobiotica; 1982 Sep; 12(9):567-79. PubMed ID: 6818776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism between stereoisomeric amphetamines, amphetamine derivatives and other monoamine oxidase inhibitors.
    Parmar SS
    Biochem Pharmacol; 1966 Oct; 15(10):1497-505. PubMed ID: 4382014
    [No Abstract]   [Full Text] [Related]  

  • 24. 1-Benzylcyclopropylamine and 1-(phenylcyclopropyl)methylamine: an inactivator and a substrate of monoamine oxidase.
    Silverman RB; Zieske PA
    J Med Chem; 1985 Dec; 28(12):1953-7. PubMed ID: 4068012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoamine oxidase inhibitory properties of milacemide in rats.
    Truong DD; Diamond B; Pezzoli G; Mena MA; Fahn S
    Life Sci; 1989; 44(15):1059-66. PubMed ID: 2784529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoamine oxidase. Its inhibition.
    Youdim MB
    Mod Probl Pharmacopsychiatry; 1975; 10():65-88. PubMed ID: 1101049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
    Janssens de Varebeke P; Cavalier R; David-Remacle M; Youdim MB
    J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo mammalian metabolism of methylamine and methylurea and their metabolic interrelationship.
    Dar MS; Bowman ER
    Drug Metab Dispos; 1985; 13(6):682-9. PubMed ID: 2867871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases.
    Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ
    Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498
    [No Abstract]   [Full Text] [Related]  

  • 31. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Monoamine tetrazolium reductase of rat heart mitochondria.
    Sen R; Parmar SS; Guha SR
    J Pharm Pharmacol; 1973 Oct; 25(10):835-7. PubMed ID: 4149751
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain.
    Yamada N; Takahashi S; Todd KG; Baker GB; Paetsch PR
    J Pharm Sci; 1993 Sep; 82(9):934-7. PubMed ID: 7901387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.
    McDonald GR; Olivieri A; Ramsay RR; Holt A
    Pharmacol Res; 2010 Dec; 62(6):475-88. PubMed ID: 20832472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New data on monoamine oxidase inhibitors].
    Gorkin VZ
    Vestn Akad Med Nauk SSSR; 1971; 26(11):23-8. PubMed ID: 4942003
    [No Abstract]   [Full Text] [Related]  

  • 36. Some cardiovascular effects of monoamine oxidase inhibitors in unanaesthetized rats.
    Marwood JF; Huston V; Wall KT
    Clin Exp Pharmacol Physiol; 1985; 12(2):161-8. PubMed ID: 3839173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P; Artigas F
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Importance of the initial monoamine oxidase activity for the development of the activating or inhibiting action of indolylhydrazides].
    Safrazbekian RR; Sukasian RS; Arzanunts EM
    Vopr Med Khim; 1979; 25(3):311-4. PubMed ID: 452498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.
    Benedetti MS; Boucher T; Carlsson A; Fowler CJ
    Biochem Pharmacol; 1983 Jan; 32(1):47-52. PubMed ID: 6830619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion.
    Cutillas B; Ambrosio S; Unzeta M
    Neurosci Lett; 2002 Aug; 329(2):165-8. PubMed ID: 12165403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.